重定位的瘤病毒被设计为重塑瘤微环境,用于质母细胞瘤免疫疗法
Federico Giovannoni1, Craig A Strathdee2, Camilo Faust Akl1,3
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nature cancer
|December 4, 2025
概括
研究人员设计了一种针对质母细胞瘤 (GBM) 的新型瘤性病毒疗法. 这种修改后的简单疹病毒1 (HSV-1) 显示出增强的瘤活性,瘤向和免疫刺激,在临床前模型中显著改善了生存率.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 质母细胞瘤 (GBM) 是一种高度攻击性的脑瘤,以其对免疫疗法的耐药性而闻名.
- 目前对GBM的治疗选择有效性有限,需要开发新的治疗策略.
研究的目的:
- 为质母细胞瘤 (GBM) 病毒免疫疗法设计一种基于简单疹病毒1 (HSV-1) 的型病毒平台.
- 为了增强病毒的瘤解毒活性,瘤特异性,安全性,以及用于GBM治疗的成像能力.
主要方法:
- 麦金泰尔株的HSV-1发生了突变,以增加病毒传播,瘤治疗潜力和PET追踪能力,同时防止神经元感染.
- 引入了MicroRNA目标磁带,以减弱健康脑细胞中的病毒复制.
- 病毒包膜蛋白 (gD) 被设计为使用EGFR或整体素结合剂对GBM细胞进行特定向.
- 五种免疫调节剂 (IL-12,抗PD1,T细胞激活剂,15-hydroxyprostagline脱酶,抗TREM2) 被纳入,以重塑瘤微环境 (TME).
主要成果:
- 工程病毒的单次内注射在临床前的GBM模型中显著增加了生存率.
- 该疗法促进了T细胞,自然杀手 (NK) 细胞和TME内的髓状细胞的强有力的瘤特异性反应.
- 工程病毒显示了重定位的特异性,增强的安全性和可追溯性,以及强大的细胞毒性和免疫刺激作用.
结论:
- 工程化瘤病毒代表了质母细胞瘤免疫治疗的有希望的,多方面的治疗候选者.
- 这种新的平台结合了瘤治疗活性和向免疫调节,以克服GBM对治疗的抗性.
- 开发的病毒是安全的,可追溯的,并且在GBM治疗中具有显著的临床转化潜力.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.0K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.3K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
